Abstract:Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women. NudC domain containing 1 (NUDCD1) was identified as an oncoprotein which was activated or over-expressed in various human cancers. We aimed to investigate the effects and mechanisms of NUDCD1 in human CRC. The expression of NUDCD1 in CRC and pericarcinous tissues from 70 CRC patients were determined by real-time PCR, western blotting, and immunohistochemistry. The correlation between the expression of NUDCD1 and clinical characteristics was analyzed. The expression of NUDCD1 in five CRC cell lines and normal colon mucosal epithelial cell line was measured by real-time PCR. Then we knock down NUDCD1 in HCT116 and HT 29 cells. The cell viability assay, scratch assay, migration and invasion assay and flow cytometry were used to analyze NUDCD1's effects on the proliferation, migration, invasion, cell cycle and apoptosis of CRC cells. NUDCD1's effects on CRC xenografts of nude mice was also determined. Results showed that the expression of NUDCD1 was much higher in CRC tissues than that in pericarcinous tissues. Over-expression of NUDCD1 in human CRC tissues was significantly associated with lymph node metastasis, distant metastasis, and advanced stages. The expression of NUDCD1 was higher in all of the CRC cell lines than that in normal colon epithelial mucosal cells. To knockdown NUDCD1 resulted in significant decreases in cell viability and proliferation, decreased protein expression of N-cadherin and increased protein expression of E-cadherin which were biomarkers of EMT, arrested the cell cycle and increased apoptosis via down-regulated cyclin D1, Bcl2, and up-regulated cleaved-caspase3. Furthermore, to knockdown NUDCD1 inactivated IGF1R-ERK1/2 signaling pathway in vitro and in vivo, and suppressed the xenografts of CRC. In conclusion, NUDCD1 promotes the carcinogenesis and metastasis of CRC through inducing EMT and inhibiting apoptosis, which suggests NUDCD1 be a potential biomarker for CRC.

Overexpression of NELFCD Promotes Colorectal Cancer Cells Proliferation, Migration, and Invasion.

CBLN2 Overexpression Inhibits Colorectal Cancer Progression and Improves Immunotherapy Responses

Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression

The Lncrna NEAT1 Inhibits Mirna-216B and Promotes Colorectal Cancer Progression by Indirectly Activating YY1

RNA-binding Protein CELF1 Enhances Cell Migration, Invasion, and Chemoresistance by Targeting ETS2 in Colorectal Cancer

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

NUDCD1 Promotes Metastasis Through Inducing EMT and Inhibiting Apoptosis in Colorectal Cancer.

Long Noncoding RNA LINC01594 Inhibits the CELF6-mediated Splicing of Oncogenic CD44 Variants to Promote Colorectal Cancer Metastasis

NELFE Promoted Pancreatic Cancer Metastasis and the Epithelial‑to‑mesenchymal Transition by Decreasing the Stabilization of NDRG2 Mrna.

The RNA-Binding Protein NELFE Promotes Gastric Cancer Growth and Metastasis Through E2F2

The Noncoding Function of NELFA Mrna Promotes the Development of Oesophageal Squamous Cell Carcinoma by Regulating the Rad17‐RFC2‐5 Complex

The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition

Cd151 Promotes Colorectal Cancer Progression By A Crosstalk Involving Ceacam6, Lgr5 And Wnt Signaling Via Tgf Beta 1

EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis

Ring Finger Protein 2 Promotes Colorectal Cancer Progression by Suppressing Early Growth Response 1

CDCA3 Mediates P21-Dependent Proliferation by Regulating E2F1 Expression in Colorectal Cancer

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1

NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells Through Downregulating CCND1 and Prb1-Ser807/811

Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT

RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy.